Director/PDMR Shareholding
6 March 2024 15:05 GMT Transaction by Person Discharging Managerial Responsibilities AstraZeneca PLC (the Company) announced that, on 5 March 2024, an award of the Company's ordinary shares of $0.25 each (Ordinary Shares) vested to Pascal Soriot, Executive Director and Chief Executive Officer, under the terms of the AstraZeneca Deferred Bonus Plan (AZDBP). The AZDBP award was granted on 5 March 2021, following the deferral of a portion of Mr Soriot's annual bonus in respect of 2020 performance into Ordinary Shares, and vested on completion of the three-year holding period.